Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
This shortage led doctors to prescribe Ozempic for off-label use to promote weight loss in patients with obesity
[1] [2] Hashimoto's thyroiditis is an autoimmune condition in which the immune system attacks the thyroid gland, leading to chronic inflammation and often resulting in hypothyroidism (underactive thyroid)
The study, Medicaid Coverage and Prior Authorization for Antiobesity Glucagon-Like Peptide-1 Receptor Agonists: A Cross- Sectional Study of State Policies, was published on November 21, 2025 in the Journal of General Internal Medicine
GLP-1 medications, however, can help many people lose a significant amount of weight and lower their risks for these other conditions
The SURMOUNT-5 head-to-head trial directly compared Zepbound to Wegovy, with results published in The New England Journal of Medicine: The addition of GIP receptor activation unlocks approximately 6% additional fat loss compared to GLP-1-only medications, while also helping preserve muscle mass better
